Gold prices set for weekly drop as strong dollar weighs; Trump tariffs in focus
FREMONT, Calif.—Mark McKechnie, Chief Financial Officer and Treasurer of ACM Research, Inc. (NASDAQ:ACMR), a semiconductor equipment manufacturer with a market capitalization of $1.47 billion and impressive year-to-date gains of over 50%, recently sold 15,000 shares of the company’s Class A Common Stock. The transaction, conducted on February 6, was completed at a price of $22 per share, amounting to a total value of $330,000. This sale was executed under a Rule 10b5-1 trading plan that McKechnie adopted on March 7, 2024. According to InvestingPro data, the stock is currently trading near its Fair Value, with a GREAT financial health score of 3.15, though technical indicators suggest the stock may be in overbought territory.
In addition to the sale, McKechnie exercised stock options to acquire 15,000 shares at a price of $5.6 per share, totaling $84,000. Following these transactions, McKechnie holds 900 shares directly. For deeper insights into ACMR’s valuation metrics and 13 additional ProTips, investors can access the comprehensive Pro Research Report available on InvestingPro.
In other recent news, ACM Research has been recognized as a high-growth opportunity by Kerrisdale Capital. The firm’s endorsement has highlighted ACM Research’s role as a top supplier of wafer cleaning tools in China and its significant contribution to the expansion of the domestic semiconductor manufacturing industry. Over the past six years, the company’s revenue has increased tenfold, a growth trajectory that Kerrisdale Capital expects to continue, especially in the Chinese market.
Kerrisdale Capital has also projected that ACM Research will become a strong competitor to global wafer fabrication equipment players as it expands its market share beyond China. The firm notes that ACM Research’s strategic importance is likely to be enhanced by any new U.S. legislation that further limits China’s ability to import wafer fabrication equipment.
In terms of valuation, Kerrisdale Capital has suggested that ACM Research’s shares could potentially reach a market capitalization of over $10 billion. This projection is based on the company’s current market capitalization of $5.9 billion in China, where its subsidiary, ACM Research (Shanghai) Inc., is publicly traded. Kerrisdale Capital has emphasized that the current valuation of ACM Research on NASDAQ does not accurately reflect the company’s true value, especially considering its 82% ownership of its Shanghai-listed subsidiary. These recent developments suggest a potential for growth in the U.S. market for ACM Research.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.